SciTransfer
Organization

POLYVATION BV

Dutch polymer SME producing functionally graded additive manufacturing scaffolds for biomedical and advanced manufacturing applications.

Technology SMEmanufacturingNLSMENo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€250K
Unique partners
20
What they do

Their core work

Polyvation BV is a Groningen-based polymer technology SME that designs and fabricates advanced functional polymer structures, with a focus on additive manufacturing of scaffolds with spatially varying material properties. Their work on functionally graded scaffolds — structures where composition or mechanical properties change across the volume — places them at the intersection of materials science and precision manufacturing. They contribute industrial and technical expertise to academic-led consortia, including serving as an industry host in Marie Curie training networks. The company's name ("Poly" + "vation") and project footprint together suggest a core identity built around polymer innovation for biomedical and advanced manufacturing applications.

Core expertise

What they specialise in

Additive manufacturing of polymer scaffoldsprimary
1 project

FAST (2015–2019) was directly focused on functionally graded scaffolds produced by hybrid additive manufacturing, the project for which Polyvation received EUR 249,625 as a participant.

Functionally graded materialsprimary
1 project

FAST's full title — 'Functionally graded Additive Manufacturing scaffolds by hybrid manufacturing' — makes this the defining technical specialty of their funded H2020 work.

Nanomedicine materials and industrial translationsecondary
1 project

NANOMED (2016–2019) was an MSCA-ITN training network on nanomedicine, where Polyvation participated as an industrial third party — likely hosting fellows or providing applied polymer expertise.

Biomedical polymer applicationsemerging
2 projects

Both FAST (scaffolds for tissue engineering contexts) and NANOMED (drug delivery and nanoparticle systems) point toward a biomedical application thread, though neither project makes the clinical context explicit.

Evolution & trajectory

How they've shifted over time

Early focus
Additive manufacturing, biomedical scaffolds
Recent focus
Nanomedicine industrial partnership

With only two projects, both launched within a year of each other (2015 and 2016) and running concurrently through 2019, there is no meaningful early-to-late trajectory to analyze — this is a single cohort of activity rather than a progression. No keyword data is available from CORDIS to differentiate their focus within that period. What can be said is that Polyvation entered H2020 simultaneously on two fronts: a manufacturing RIA focused on scaffold fabrication, and an MSCA training network in nanomedicine, suggesting from the outset a deliberate positioning across both applied manufacturing and life-science research communities.

Their dual entry into manufacturing and nanomedicine simultaneously suggests Polyvation is building toward biomedical polymer applications — a logical trajectory for a polymer SME seeking to move up the value chain from fabrication into healthcare-adjacent markets.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European10 countries collaborated

Polyvation has never served as a project coordinator — they enter consortia as a participant or third party, contributing specialist capability rather than driving the project agenda. Despite only two projects, they accumulated 20 unique consortium partners across 10 countries, which reflects participation in large, well-networked consortia rather than small bilateral arrangements. This pattern is typical of an SME that is recruited for its specific technical niche and that gains broad European exposure without taking on administrative leadership risk.

Polyvation has reached 20 unique partners across 10 countries through just two projects, reflecting the large consortia typical of RIA and MSCA-ITN schemes. Their network is European in scope with no documented focus on any particular geographic cluster beyond the Netherlands.

Why partner with them

What sets them apart

Polyvation occupies a rare niche as a small polymer manufacturer with simultaneous credibility in precision fabrication (functionally graded additive manufacturing) and biomedical research networks (MSCA nanomedicine). For consortium builders, this means they bring both hands-on production capability and the legitimacy of having worked within academic-led life science projects — a combination that pure research institutes and pure manufacturers cannot offer alone. Located in Groningen, they sit close to the University of Groningen's strong polymer and biomedical research ecosystem, which likely underpins their access to these consortia.

Notable projects

Highlights from their portfolio

  • FAST
    Their sole directly funded H2020 project (EUR 249,625), addressing a technically specific challenge — producing scaffolds with graded material properties via hybrid additive manufacturing — that sits at the frontier of both manufacturing process engineering and biomedical material design.
  • NANOMED
    Participation as an industrial third party in a Marie Curie training network signals that Polyvation is recognized as a credible industry host for early-career researchers in nanomedicine, a role that builds long-term academic-industry network value beyond direct project funding.
Cross-sector capabilities
Health and biomedical devices (scaffold-based tissue engineering, nanomedicine materials)Research training and academic-industry knowledge transfer (MSCA industrial host experience)Advanced materials (functionally graded and composite polymer structures)
Analysis note: Only 2 projects are on record, both from 2015–2016, with no CORDIS keyword data available for either. Expertise inference relies primarily on project titles and the company name. No post-2019 H2020 activity is recorded; the company may have transitioned to Horizon Europe or reduced its EU project activity. The biomedical scaffold interpretation is reasonable but unverified — direct review of Polyvation's website or publications would be needed to confirm their current technical focus.
More in Manufacturing & Industry 4.0
See all Manufacturing & Industry 4.0 organizations